Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
| Metric | AMGN | EW |
|---|
| Close | 466.01 | 92.01 |
| Market Cap | $254B | $53.6B |
| 1M | +10.56% | +6.59% |
| P/E (TTM) | 28.5 | 53.7 |
| Forward P/E | 17.1 | 31.0 |
| P/E 5-Yr Percentile | 68 | 100 |
| P/S | 6.5 | 8.3 |
| P/B | 21.3 | 5.1 |
| Dividend Yield | 3.21% | — |
| Latest Quarter Revenue | $10.1B | $1.7B |
| Revenue YoY | +9.5% | +13.6% |
| Gross Margin | 72.0% | 77.5% |
| Latest Quarter EPS | 4.37 | 0.42 |
| Avg Post-Earnings Move | ±5.2% | ±3.9% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | 2 / 2 |
| Shareholder Yield | 2.08% | 2.25% |
| 90-Day Net Insider Buying | −$4.1M | −$3.5M |
AMGN · Revenue, Last 8 Quarters ($B)
EW · Revenue, Last 8 Quarters ($B)
